Document Detail


Sedation during flexible bronchoscopy in patients with pre-existing respiratory failure: Midazolam versus Midazolam plus Alfentanil.
MedLine Citation:
PMID:  20016132     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: The use of sedation during flexible bronchoscopy (FB) is undisputed; however, the combination of benzodiazepines and opiates, although reasonable, is suggested to cause hypoventilation, particularly in patients with pre-existing respiratory failure. OBJECTIVES: To assess respiratory function during FB. METHODS: Transcutaneous PCO(2 )(PtcCO(2)), oxygen saturation, patients' tolerance, time after FB until recovery and application of drug dosage were assessed in patients receiving either midazolam with alfentanil (n = 15) or midazolam alone (n = 15) for sedation for FB. RESULTS: There were no differences in PtcCO(2) values during FB between the two groups (all p > 0.05). However, PtcCO(2 )significantly increased over time in both groups (both p < 0.001; RM-ANOVA on ranks). Minimum oxygen saturation (SaO(2)) [89 (interquartile range 79.8/92.8) vs. 86 (interquartile range 82.3/87.8)%; p = 0.46] and the duration until recovery, i.e., achieving an ALDRETE score of > or =9 [30 (interquartile range 10/90) vs. 10 (interquartile range 10/105) min; p = 0.68] were comparable for monosedation and combined sedation, respectively. The total amount of midazolam [4.0 (interquartile range 4.0/4.0) vs. 2.0 (interquartile range 2.0/2.0) mg; p < 0.001] was lower in patients receiving combined sedation. Significantly lower scores for pain and asphyxia, and a clear tendency to less nausea and cough were reported by patients receiving combined sedation. CONCLUSIONS: Combined sedation during FB produced a comparable degree of desaturation and hypoventilation, and is associated with a comparable time to full recovery compared to monosedation in patients with pre-existing respiratory failure. Importantly, FB using combined sedation is better tolerated by patients despite only 50% midazolam consumption.
Authors:
Michael Dreher; Emelie Ekkernkamp; Jan Hendrik Storre; Hans-Joachim Kabitz; Wolfram Windisch
Publication Detail:
Type:  Comparative Study; Journal Article     Date:  2009-12-14
Journal Detail:
Title:  Respiration; international review of thoracic diseases     Volume:  79     ISSN:  1423-0356     ISO Abbreviation:  Respiration     Publication Date:  2010  
Date Detail:
Created Date:  2010-03-05     Completed Date:  2010-05-26     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0137356     Medline TA:  Respiration     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  307-14     Citation Subset:  IM    
Copyright Information:
Copyright 2009 S. Karger AG, Basel.
Affiliation:
Department of Pneumology, University Hospital, Freiburg, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Alfentanil / administration & dosage*,  adverse effects
Anesthesia Recovery Period
Anesthetics, Intravenous / administration & dosage*,  adverse effects
Blood Gas Monitoring, Transcutaneous
Bronchoscopy*
Carbon Dioxide / blood
Female
Heart Rate
Humans
Male
Midazolam / administration & dosage*,  adverse effects
Middle Aged
Oxygen / blood
Respiratory Insufficiency / blood*
Chemical
Reg. No./Substance:
0/Anesthetics, Intravenous; 124-38-9/Carbon Dioxide; 59467-70-8/Midazolam; 71195-58-9/Alfentanil; 7782-44-7/Oxygen
Comments/Corrections
Comment In:
Respiration. 2010;79(4):276   [PMID:  20090285 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Order Out of Chaos in the Hybrid Plant Nucleus.
Next Document:  Copy Number Variation and Missense Mutations of the Agouti Signaling Protein (ASIP) Gene in Goat Bre...